Greater risks of chemotherapy toxicity in elderly patients with cancer.
about
Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice GuideAdjuvant treatment for older women with invasive breast cancerDiscovering Outliers of Potential Drug Toxicities Using a Large-scale Data-driven ApproachEfficacies and adverse reactions of modified vitamin supplement programs before pemetrexed chemotherapy as a second-line treatment against epidermal growth factor receptor (EGFR) mutant wild-type lung adenocarcinoma.Generalizability of toxicity data from oncology clinical trials to clinical practice: toxicity of irinotecan-based regimens in patients with metastatic colorectal cancerCarfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE studyPatient, Physician and Contextual Factors Are Influential in the Treatment Decision Making of Older Adults Newly Diagnosed with Symptomatic Myeloma.Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors.The risk factors of toxicity during chemotherapy and radiotherapy in breast cancer patients according to the presence of BRCA gene mutation.Quality of life after cancer-How the extent of impairment is influenced by patient characteristics.Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older.Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy.Calcaneal acrometastasis from urothelial carcinoma of the ureter: a case report and literature review.Older adults and cancer treatment.Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximabSquamous cell carcinoma of the head and neck in the elderly.Breast cancer in the elderly-Should it be treated differently?Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.Side effects of standard adjuvant and neoadjuvant chemotherapy regimens according to age groups in primary breast cancer.Potential drug interactions in patients with a history of cancer.Improving Adherence to Cancer Treatment by Addressing Quality of Life in Patients With Advanced Gastrointestinal Cancers.Transplantation with bone marrow stromal cells promotes wound healing under chemotherapy through altering phenotypes.Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.Using Information Technology in the Assessment and Monitoring of Geriatric Oncology Patients.Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611).Engaging the older cancer patient; Patient Activation through Counseling, Exercise and Mobilization - Pancreatic, Biliary tract and Lung cancer (PACE-Mobil-PBL) - study protocol of a randomized controlled trial
P2860
Q26749476-4821A88C-F77A-4595-8EA5-EAB6C3BE3710Q28066744-F86DFD1D-7B1A-4CF7-9C60-7F6A8B262C99Q31140868-188B52F6-536E-48A6-A267-4A2457EE9C5AQ33427414-529A80C9-E69F-4695-B12D-AF501EDC8289Q33519035-9A9DB2BC-15F7-43EE-BDAB-C6A4333827C5Q33626064-AF265D3F-E2D9-48CE-8B57-954FD5D184E5Q34781514-388691AC-D68C-41C2-AC63-04942848B101Q35771257-8BD52C85-29CE-4579-91F6-EA9A2DA1873CQ35867279-6F6B55C2-D7B6-4245-B828-EC4ACCD32DB0Q36159779-AAEF961B-A1DD-4A29-BC77-36E22803DCC5Q36406979-5C9F5388-49BF-40B6-AB54-9811B36972F3Q36500074-83FD0DBD-BA84-4360-B490-A811D58873ABQ36565645-91B22907-DAE7-491C-8783-B57057EADF12Q36776892-4B7F2446-A3BF-485F-85F0-93EBEE115529Q37023167-AA246ADD-EA9B-41F9-AD00-8FFE95A34BC7Q37146157-775ED42A-36E7-43EB-9E7A-82DA537216E2Q37392126-EDDDA4E5-1E3B-4200-9323-0195149CC7AAQ37392327-80259251-CC37-476E-A069-A12A381B4675Q37474079-A14FE7DE-B316-41B3-849E-E32CCFEEAD54Q37677748-8CDCB494-5C9D-49CA-B871-6906DA766A79Q37719619-44832031-BB3B-40F3-A98D-2B44242B5F26Q40938852-389648FD-F184-4A2F-B59D-EEAABEA7F134Q41831790-916119D2-5259-4589-9AEF-4538F5AEE7CEQ45783553-7CC7B5F4-14D6-4F62-9AF5-192926E75DC1Q47128205-8E6EC3CF-544D-418A-A374-5F59AF3A1BD4Q52364992-849D3581-5182-4D3A-AD8F-FA4E41FED7A1Q52577099-388D1C8D-92E3-498A-925C-084EB5FFABC5Q59128550-3643C9FF-A039-48CF-901E-6DBC16CF1F63
P2860
Greater risks of chemotherapy toxicity in elderly patients with cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Greater risks of chemotherapy toxicity in elderly patients with cancer.
@ast
Greater risks of chemotherapy toxicity in elderly patients with cancer.
@en
type
label
Greater risks of chemotherapy toxicity in elderly patients with cancer.
@ast
Greater risks of chemotherapy toxicity in elderly patients with cancer.
@en
prefLabel
Greater risks of chemotherapy toxicity in elderly patients with cancer.
@ast
Greater risks of chemotherapy toxicity in elderly patients with cancer.
@en
P1476
Greater risks of chemotherapy toxicity in elderly patients with cancer.
@en
P2093
Lazzaro Repetto
P433
P577
2003-11-01T00:00:00Z